Loading
Cancer Diagnosis and Treatment / Cancer and Skin Lesions · Journal article
Skin the Journal of Cutaneous Medicine · September 8, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a single case report documenting uneventful healing and absence of local recurrence after Mohs micrographic surgery for a cutaneous metastasis of endometrial carcinoma in one 72-year-old patient. The authors claim this is the first such case in the literature and suggest the procedure may be a palliative and cosmetic option for selected patients with visceral cancer cutaneous metastases, but the evidence is too limited to support efficacy claims or guide practice.
Single case report. One 72-year-old female with metastatic endometrial carcinoma and a cutaneous scalp nodule confirmed histologically as metastatic disease.. Intervention: Mohs micrographic surgery with palliative, cosmetic and symptomatic intent.. n = 1.
A 72-year-old female with metastatic endometrial carcinoma presented with a tender, rapidly enlarging scalp nodule confirmed as cutaneous metastasis. Mohs micrographic surgery was performed for palliative, cosmetic and symptomatic treatment. Surgical site healing occurred uneventfully with no evidence of local recurrence on follow-up.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
While the case demonstrates technical feasibility and immediate tolerability of Mohs surgery in this setting, a single patient outcome does not establish efficacy, durability of response, or indications for use. Clinicians should not alter practice based on this report; further evidence from systematic series or comparative studies would be needed to guide patient selection.
A single case report of an uncommon clinical scenario with no control group, comparative data, or systematic evidence; describes feasibility and tolerability in one patient but cannot establish efficacy or guide clinical practice.
As stated by the source record.
Quoted from the source exactly as published.
While the case demonstrates technical feasibility and immediate tolerability of Mohs surgery in this setting, a single patient outcome does not establish efficacy, durability of response, or indications for use. Clinicians should not alter practice based on this report; further evidence from systematic series or comparative studies would be needed to guide patient selection.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background Cutaneous metastases of visceral malignancies are rare, difficult to treat, and portend a poor prognosis. This brief article discusses the use of Mohs micrographic surgery in a patient with cutaneous metastasis of endometrial carcinoma. Case Presentation A 72-year-old female with a history of metastatic endometrial carcinoma presented with a new tender, rapidly enlarging nodule on the scalp that was confirmed to be a cutaneous metastasis of her underlying gynecologic malignancy. She underwent Mohs micrographic surgery for palliative, cosmetic and symptomatic treatment. Surgical site healing occurred uneventfully and follow up showed no evidence of local recurrence. Discussion The case report demonstrates, that surgical excision of cutaneous metastases from visceral malignancies using the micrographic technique allows for symptomatic improvement and prevent recurrence at the surgery site. To our knowledge, this is the first reported case of a metastatic cutaneous endometrial cancer treated with Mohs micrographic surgery. Conclusion Mohs micrographic surgery can play a role in metastatic visceral cancers and should be considered as an adjunctive therapy for appropriate patients. The goal of improving quality of life in these patients should be duly balanced with the morbidity and recovery of the procedure. This report further adds to the limited body of literature supporting the use of Mohs micrographic surgery in cases of cutaneous metastases.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.